Sulfisoxazole
Sulfisoxazole is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Urinary tract infection (pyelonephritis and cystitis)
- Nocardia
- Plasmodium falciparum, resistant to chloroquine.
- Toxoplasmosis in combination with pyrimethamine (sulfadiazine preferred)
- Otitis media (pediatric) in combination with PCN also trachoma including inclusion conjunctivitis, chancroid, meningococcal meningitis prophylaxis when sulfonamide-sensitive group A strains are known to prevail and meningitis caused by H. influenzae in combination with streptomycin (pediatric suspension)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Urinary tract infection (pyelonephritis and cystitis)
- Nocardia
- Plasmodium falciparum, resistant to chloroquine.
- Toxoplasmosis in combination with pyrimethamine (sulfadiazine preferred)
- Otitis media (pediatric) in combination with PCN also trachoma including inclusion conjunctivitis, chancroid, meningococcal meningitis prophylaxis when sulfonamide-sensitive group A strains are known to prevail and meningitis caused by H. influenzae in combination with streptomycin (pediatric suspension)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this entry is available only to subscribers.